Metraipolis › archive › dc_674b87449bca
Protocol for establishing a chemoresistant orthotopic triple-negative breast cancer patient-derived xenograft model for preclinical drug testing — Europe PMC PMID:41774544
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41774544
- DOI
- 10.1016/j.xpro.2026.104394
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T10:05:12.329Z
- SHA-256 of the archived text
386d644604c0fe9dbfaeaca187ec93c70e6b3f2875a37214bf113a11b27c0fa8- Stable URL of this page
https://metraipolis.com/documento/dc_674b87449bca
How to cite
Protocol for establishing a chemoresistant orthotopic triple-negative breast cancer patient-derived xenograft model for preclinical drug testing — Europe PMC PMID:41774544 — Europe PMC (en), https://europepmc.org/article/MED/41774544 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_674b87449bca (Metraipolis archive dc_674b87449bca, sha256 386d644604c0fe9dbfaeaca187ec93c70e6b3f2875a37214bf113a11b27c0fa8)
BibTeX
@misc{dc674b87449bca,
title = {Protocol for establishing a chemoresistant orthotopic triple-negative breast cancer patient-derived xenograft model for preclinical drug testing — Europe PMC PMID:41774544},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41774544},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_674b87449bca; sha256 386d644604c0fe9dbfaeaca187ec93c70e6b3f2875a37214bf113a11b27c0fa8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41774544. Agents can read the archived copy with the MCP tool read_document.